Roche Pharmaceutical Development and Sales Overview

YTD Sep 2022: Diagnostics Division regional sales Strong base business growth across all regions North America +20% ~28% of divisional sales EMEA¹ -13% ~33% of divisional sales Latin America -3% ~6% of divisional sales Asia Pacific +28% ~33% of divisional sales Growth rates at CER (Constant exchange Rates); 1 Europe, Middle East and Africa Roche 36 56

View entire presentation